Tag Archives: IPO

Tel Aviv Office to Host Capital Markets Roundtable for the Life Sciences Industry

Greenberg Traurig’s Tel Aviv office is collaborating with partners BNY Mellon and H.C. Wainwright & Co. LLC to host a morning roundtable focused on capital markets options for the life sciences industry. The event will take place February 27th, 9:00 at Greenberg Traurig’s Tel Aviv office located in the Azrieli Round Tower (30th Floor). Topics … Continue Reading

Convertible Promissory Bridge Notes and Simple Agreements for Future Equity

Companies often issue convertible promissory “bridge” notes when they are at an early stage and are in search of capital. A convertible promissory bridge note is a short-term debt instrument that, in addition to the standard terms (such as the principal amount owed, the interest rate, the maturity date, and default provisions), also provides that … Continue Reading

Greenberg Traurig Maher Assists Tel Aviv-based Adgorithms Ltd. in $125 million London IPO

Greenberg Traurig Maher (GTM) represented Liberum, Adgorithms’ nominated adviser and broker, on its $125 million IPO on AIM, the London Stock Exchange’s international market for growing companies. The team was led by Andrew Caunt in London, assisted by associate Andrew Ross. Founded in 2010, Adgorithms is a software company which operates in the high growth … Continue Reading

A View from Israel: Expect More Activity From Buyout Funds and Distressed Players

It is commonplace to note the vigorous market for inbound investment and M&A transactions involving high-tech companies in Israel. Hardly a week goes by without a deal. Between 2002-2011, Israeli high-tech companies raised $15 billion from investors, and in the same period owners received more than $37 billion in proceeds from M&A and IPO exits. There were approximately 85 acquisitions in 2011 alone. These trends have continued into 2012.… Continue Reading